Literature DB >> 33484419

Circulating lipids and glioma risk: results from the UK Biobank, Nurses' Health Study, and Health Professionals Follow-Up Study.

David J Cote1,2, Stephanie A Smith-Warner3,4, Jordan H Creed5, Jeremy Furtado4, Travis Gerke5, Molin Wang6,3, Youngchul Kim5, Meir J Stampfer6,3,4, Kathleen M Egan5.   

Abstract

PURPOSE: Evidence is mixed on whether cholesterol plays a role in the pathogenesis of glioma. We explored the associations between circulating lipids and glioma risk in three prospective cohorts.
METHODS: Using prospective data from the UK Biobank, we examined the associations of total cholesterol (TC), high- and low-density lipoprotein cholesterol (HDL-C, LDL-C), and triglycerides (TG) with glioma risk in multivariable (MV)-adjusted Cox proportional hazards models. Within the Nurses' Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS), we carried out a matched, nested case-control study to examine these same associations.
RESULTS: In the UK Biobank, 490 gliomas accrued over 2,358,964 person-years. TC was not significantly associated with glioma risk (MV HR = 1.20, 95% CI 0.89-1.61 for highest quartile vs. lowest, p-trend = 0.24). In 4-year lagged analyses (n = 229), higher TC was associated with significantly higher risk of glioma in men (MV HR = 2.26, 95% CI 1.32-3.89, p-trend = 0.002) but not women (MV HR = 1.28, 95% CI 0.61-2.68, p-trend = 0.72); similar findings emerged for HDL-C and, to a lesser extent, LDL-C. In the NHS/HPFS, no significant associations were found between cholesterol and glioma risk. No significant associations were identified for TG.
CONCLUSION: In the UK Biobank, higher prediagnostic TC and HDL-C levels were associated with higher risk of glioma in 4-year lagged analyses, but not in non-lagged analyses, in men only. These findings merit further investigation, given that there are few risk factors and no reliable biomarkers of risk identified for glioma.

Entities:  

Keywords:  Cholesterol; Cohort; Epidemiology; Glioma; Risk; UK Biobank

Mesh:

Substances:

Year:  2021        PMID: 33484419      PMCID: PMC8856012          DOI: 10.1007/s10552-021-01391-8

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  27 in total

1.  Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures.

Authors:  Hideki Hayashi; Robert B Campenot; Dennis E Vance; Jean E Vance
Journal:  J Biol Chem       Date:  2004-01-06       Impact factor: 5.157

2.  Serum cholesterol concentration and risk of primary brain tumours.

Authors:  P Knekt; A Reunanen; L Teppo
Journal:  BMJ       Date:  1991-01-12

3.  5 year mortality predictors in 498,103 UK Biobank participants: a prospective population-based study.

Authors:  Andrea Ganna; Erik Ingelsson
Journal:  Lancet       Date:  2015-06-03       Impact factor: 79.321

4.  An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers.

Authors:  Genaro R Villa; Jonathan J Hulce; Ciro Zanca; Junfeng Bi; Shiro Ikegami; Gabrielle L Cahill; Yuchao Gu; Kenneth M Lum; Kenta Masui; Huijun Yang; Xin Rong; Cynthia Hong; Kristen M Turner; Feng Liu; Gary C Hon; David Jenkins; Michael Martini; Aaron M Armando; Oswald Quehenberger; Timothy F Cloughesy; Frank B Furnari; Webster K Cavenee; Peter Tontonoz; Timothy C Gahman; Andrew K Shiau; Benjamin F Cravatt; Paul S Mischel
Journal:  Cancer Cell       Date:  2016-10-13       Impact factor: 31.743

5.  Serum cholesterol concentration and primary malignant brain tumors: a prospective study.

Authors:  G D Smith; J D Neaton; Y Ben-Shlomo; M Shipley; D Wentworth
Journal:  Am J Epidemiol       Date:  1992-02-01       Impact factor: 4.897

6.  The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine.

Authors:  Paul Elliott; Tim C Peakman
Journal:  Int J Epidemiol       Date:  2008-04       Impact factor: 7.196

7.  ABO blood group and the risk of pancreatic cancer.

Authors:  Brian M Wolpin; Andrew T Chan; Patricia Hartge; Stephen J Chanock; Peter Kraft; David J Hunter; Edward L Giovannucci; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

Review 8.  Brain cholesterol: long secret life behind a barrier.

Authors:  Ingemar Björkhem; Steve Meaney
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-02-05       Impact factor: 8.311

9.  Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.

Authors:  Jared R Mayers; Chen Wu; Clary B Clish; Peter Kraft; Margaret E Torrence; Brian P Fiske; Chen Yuan; Ying Bao; Mary K Townsend; Shelley S Tworoger; Shawn M Davidson; Thales Papagiannakopoulos; Annan Yang; Talya L Dayton; Shuji Ogino; Meir J Stampfer; Edward L Giovannucci; Zhi Rong Qian; Douglas A Rubinson; Jing Ma; Howard D Sesso; John Michael Gaziano; Barbara B Cochrane; Simin Liu; Jean Wactawski-Wende; JoAnn E Manson; Michael N Pollak; Alec C Kimmelman; Amanda Souza; Kerry Pierce; Thomas J Wang; Robert E Gerszten; Charles S Fuchs; Matthew G Vander Heiden; Brian M Wolpin
Journal:  Nat Med       Date:  2014-09-28       Impact factor: 53.440

10.  Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis.

Authors:  Charlie N Saunders; Alex J Cornish; Ben Kinnersley; Philip J Law; Elizabeth B Claus; Dora Il'yasova; Joellen Schildkraut; Jill S Barnholtz-Sloan; Sara H Olson; Jonine L Bernstein; Rose K Lai; Stephen Chanock; Preetha Rajaraman; Christoffer Johansen; Robert B Jenkins; Beatrice S Melin; Margaret R Wrensch; Marc Sanson; Melissa L Bondy; Richard S Houlston
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

View more
  1 in total

1.  Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature.

Authors:  Luis F Rendon; Ishaan A Tewarie; David J Cote; Aaron Gabriel; Timothy R Smith; Marike L D Broekman; Rania A Mekary
Journal:  Drugs       Date:  2022-02-05       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.